002603 以岭藥業
按盤價 
16.890 -0.120 (-0.705%)
16.890 -0.120 (-0.705%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 9.561 | -6.686 | 12.085 | 23.626 | 14.941 |
| 總資產報酬率 ROA (%) | 7.265 | -4.783 | 8.118 | 16.158 | 11.016 |
| 投入資產回報率 ROIC (%) | 9.144 | -5.868 | 9.832 | 19.722 | 13.303 | 邊際利潤分析 |
| 銷售毛利率 (%) | 60.531 | 50.187 | 57.282 | 63.771 | 63.615 |
| 營業利潤率 (%) | 20.235 | -10.578 | 17.249 | 22.577 | 15.510 |
| 息稅前利潤/營業總收入 (%) | 19.903 | -11.942 | 16.578 | 22.346 | 15.529 |
| 淨利潤/營業總收入 (%) | 16.986 | -11.273 | 13.028 | 18.813 | 13.261 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 99.484 | 79.280 | 94.947 | 103.068 | 100.217 |
| 價值變動淨收益/利潤總額(%) | -0.010 | -4.975 | 3.877 | 0.414 | -1.409 |
| 營業外收支淨額/利潤總額(%) | -1.511 | 13.909 | -5.677 | -1.759 | -0.988 | 償債能力分析 |
| 流動比率 (X) | 1.846 | 1.663 | 1.472 | 1.496 | 1.892 |
| 速動比率 (X) | 1.285 | 0.993 | 0.919 | 1.079 | 1.327 |
| 資產負債率 (%) | 24.772 | 23.403 | 32.636 | 33.111 | 29.699 |
| 帶息債務/全部投入資本 (%) | -0.284 | -0.443 | 14.733 | 16.356 | 9.743 |
| 股東權益/帶息債務 (%) | -33,663.951 | -21,591.475 | 554.734 | 495.085 | 889.909 |
| 股東權益/負債合計 (%) | 303.857 | 327.983 | 206.624 | 202.053 | 236.627 |
| 利息保障倍數 (X) | -643.421 | -34.699 | 64.873 | 140.593 | 90.712 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 59.950 | 100.233 | 72.012 | 47.934 | 48.812 |
| 存貨周轉天數 (天) | 200.029 | 233.312 | 182.969 | 146.462 | 159.076 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 17/03/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
